Agenda

DAY 1
DAY 2
Refreshments and Non-CME/CE Bonus Presentation
In ESR1-mutated, ER+/HER2- mBC following progression on ET ORSERDU® (elacestrant): Powerful efficacy in EMERALD@, now with published real-world evidence 1-3
Friday, September 18, 2026
9:45 am
10:45 am
Session Moderator(s)
PRESENTATIONS IN THIS SESSION